Thursday, March 24, 2022 5:29:10 PM
"Market won't accept a SPAC deal.", sure they will. Most SPAC deals were killed or postponed because of market conditions and not they were not making money or more importantly couldn't be pumped. SCILEX does have a projection of $70 million in sales and a long-awaited product, SP-102 SEMDEXA, by the medical field projected to have sales in the BILLIONs. Will they "GO" in 2nd Q, it depends on the review by peers on the data and market conditions. I would give it a 60/40 at this time due to market conditions.
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM
Unitronix Corp Unveils Cryptocurrency Investment Portfolio Strategy • UTRX • Oct 2, 2024 8:40 AM
Integrated Ventures, Inc Reports Total 2024 Revenues Of $5,863,935 vs $3,862,849 for 2023. • INTV • Oct 1, 2024 9:00 AM
Nightfood Signs Letter of Intent to Acquire Los Angeles Cooking School, Integrating Automation and Robotics with World-Class Culinary Training • NGTF • Oct 1, 2024 8:30 AM
ZenaTech, Inc. (NASDAQ: ZENA) To Commence Trading Today • COOP • Oct 1, 2024 7:00 AM
Element79 Gold Corp secures loi for launching tailings reprocessing business in Arequipa, Peru • ELMGF • Oct 1, 2024 6:38 AM